Financial LP QVT, an insider at $ROIV, sold 275,000 shares of the company on 12-16-2025 for an estimated $6,305,750. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.5% of their shares of this class of stock. Following this trade, they now own 17,772,727 shares of this class of $ROIV stock.
$ROIV Insider Trading Activity
$ROIV insiders have traded $ROIV stock on the open market 48 times in the past 6 months. Of those trades, 1 have been purchases and 47 have been sales.
Here’s a breakdown of recent trading of $ROIV stock by insiders over the last 6 months:
- VIVEK RAMASWAMY has made 0 purchases and 10 sales selling 7,311,104 shares for an estimated $134,950,173.
- FINANCIAL LP QVT has made 0 purchases and 9 sales selling 2,994,614 shares for an estimated $65,369,713.
- ERIC VENKER (President & Immunovant CEO) has made 0 purchases and 17 sales selling 4,053,209 shares for an estimated $64,504,428.
- MATTHEW GLINE (CEO) has made 1 purchase buying 3,315 shares for an estimated $49,957 and 3 sales selling 1,740,000 shares for an estimated $37,723,200.
- KEITH S MANCHESTER has made 0 purchases and 4 sales selling 1,300,000 shares for an estimated $26,304,500.
- DANIEL ALLEN GOLD has made 0 purchases and 4 sales selling 1,300,000 shares for an estimated $26,304,500.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ROIV Hedge Fund Activity
We have seen 187 institutional investors add shares of $ROIV stock to their portfolio, and 185 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SB INVESTMENT ADVISERS (UK) LTD removed 19,637,525 shares (-32.8%) from their portfolio in Q3 2025, for an estimated $297,115,753
- VIKING GLOBAL INVESTORS LP removed 10,642,948 shares (-31.1%) from their portfolio in Q3 2025, for an estimated $161,027,803
- FMR LLC added 5,257,703 shares (+9.5%) to their portfolio in Q3 2025, for an estimated $79,549,046
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 5,150,000 shares (+247.3%) to their portfolio in Q3 2025, for an estimated $77,919,500
- ANCHORAGE CAPITAL GROUP, L.L.C. removed 4,832,642 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $73,117,873
- TOMS CAPITAL INVESTMENT MANAGEMENT LP removed 4,095,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $46,150,650
- PERCEPTIVE ADVISORS LLC added 4,036,996 shares (+121.2%) to their portfolio in Q3 2025, for an estimated $61,079,749
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ROIV Congressional Stock Trading
Members of Congress have traded $ROIV stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ROIV stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ROIV Analyst Ratings
Wall Street analysts have issued reports on $ROIV in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 11/11/2025
- HC Wainwright & Co. issued a "Buy" rating on 09/18/2025
- JP Morgan issued a "Overweight" rating on 09/18/2025
- Guggenheim issued a "Buy" rating on 09/18/2025
- Leerink Partners issued a "Outperform" rating on 09/18/2025
- Jefferies issued a "Buy" rating on 09/18/2025
- Goldman Sachs issued a "Buy" rating on 09/18/2025
To track analyst ratings and price targets for $ROIV, check out Quiver Quantitative's $ROIV forecast page.
$ROIV Price Targets
Multiple analysts have issued price targets for $ROIV recently. We have seen 8 analysts offer price targets for $ROIV in the last 6 months, with a median target of $23.5.
Here are some recent targets:
- Corinne Jenkins from Goldman Sachs set a target price of $33.0 on 12/15/2025
- David Risinger from Leerink Partners set a target price of $32.0 on 12/15/2025
- Douglas Tsao from HC Wainwright & Co. set a target price of $26.0 on 12/12/2025
- Samantha Semenkow from Citigroup set a target price of $26.0 on 11/11/2025
- Brian Cheng from JP Morgan set a target price of $20.0 on 09/18/2025
- Yatin Suneja from Guggenheim set a target price of $21.0 on 09/18/2025
- Chi Fong from B of A Securities set a target price of $16.5 on 09/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
